Globus Medical (GMED) Reports In-Line Q3 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Globus Medical (GMED) Reports In-Line Q3 EPS

Globus Medical Reports Third Quarter 2016 Results

November 8, 2016 4:15 PM EST

AUDUBON, Pa., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the third quarter ended September 30, 2016.

Worldwide sales decreased 1.0% as reported to $135.7 million, or a decrease of 0.7% on a constant currency basisThird quarter net income was $26.2 million, or 19.3% of salesDiluted earnings per share (EPS) were $0.27Non-GAAP diluted EPS were $0.29Non-GAAP adjusted EBITDA (AEBITDA) remained at 37.0% of salesCompany issues new 2016 guidance for sales of $560 million

David Paul, Chairman and CEO said,... More